MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Familial neurodegenerative diseases"

  • 2017 International Congress

    Living with Ataxia in Ireland 2016–a nationwide survey of 130 Irish patients with inherited Ataxia

    P. Bogdanova-Mihaylova, R. Walsh, S. Murphy (Dublin, Ireland)

    Objective: To collect real-life data from a large cohort of patients with inherited ataxia in Ireland, with special attention to the individual ataxia-related healthcare resources…
  • 2017 International Congress

    Utility of ataxia gene panel testing in diagnosing inherited ataxia: evaluation of an Irish cohort

    P. Bogdanova-Mihaylova, R. Walsh, S. Murphy (Dublin 24,, Ireland)

    Objective: To evaluate the utility of gene panel testing in a population of patients with genetically undetermined ataxia attending the Irish National Ataxia clinic. Background:…
  • 2017 International Congress

    SPG7-related ataxia in the Irish National Ataxia Clinic cohort: case series

    P. Bogdanova-Mihaylova, S. Murphy, R. Walsh (Dublin, Ireland)

    Objective: To present comprehensive clinical, optical coherence tomography (OCT) and genetic findings on SPG7 –related cohort attending the National Ataxia Clinic in Ireland. Background: Hereditary…
  • 2017 International Congress

    Neuroferritinopathy pedigree in 2 families from India

    J. Kaur, G. Singh, B. Paul (Ludhiana, India)

    Objective: The abstract provides description of first case report of two Indian families with Neuroferritinopathy (NFT) pedigree. Background: NFT is a rare autosomal dominant movement disorder caused…
  • 2016 International Congress

    Communication and language skills in Huntington’s disease

    Y. Manor, D. Shpunt, S. Naor, L. Frydman, A. Gad, A. Ezra, A. Migirov, J. Knaani, A. Socher, T. Gurevich (Tel-Aviv, Israel)

    Objective: To characterize the language and communication abilities of HD patients as reflected in tasks involving naming, verbal fluency, working memory and pragmatics. Background: Huntington's…
  • 2016 International Congress

    Emotional facial EMG responses are affected in Huntington’s disease

    C.C. Kordsachia, I. Labuschagne, J. Stout (St. Kilda, Australia)

    Objective: The aim of this study was to investigate emotional facial muscle responses in Huntington's Disease (HD). We examined induced experience-related responses when viewing emotional…
  • 2016 International Congress

    A health cost analysis for Huntington disease in Peru

    G. Silva-Paredes, M. Cornejo-Olivas, M. Inca-Martinez, K. Espinoza-Huertas, A. Vishnevetsky, P. Mazzetti, R. Urbanos-Garrido (Lima, Peru)

    Objective: To estimate economic costs of caring for an individual with Huntington disease from the patients and caregivers perspective. Background: Huntington disease (HD) is a…
  • 2016 International Congress

    Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature

    C. Wilke, J.K. Pomper, S. Biskup, C. Puskás, D. Berg, M. Synofzik (Tübingen, Germany)

    Objective: To provide a systematic clinical characterisation of C9orf72-associated parkinsonism. Background: While C9orf72 repeat expansions usually present with frontotemporal dementia (FTD) and/or amyotrophic lateral sclerosis…
  • 2016 International Congress

    Preliminary results for a study on quality of life in Huntington’s disease patients and their caregivers in Peru

    A. Vishnevetsky, M.A. Inca-Martinez, M. Illanes-Manrique, M. Cornejo-Olivas (Lima, Peru)

    Objective: To quantitatively and qualitatively explore the determinants of quality of life (QOL) in Huntington's Disease (HD) patients and their caregivers in Peru. Background: HD…
  • 2016 International Congress

    A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

    A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)

    Objective: This study includes the evaluation of a comprehensive spectrum of neurological features and the mutational screening of the SPG4/SPAST gene in patients with hereditary…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley